Macrophage Infiltration Predicts Restenosis After Coronary Intervention in Patients With Unstable Angina

Author:

Moreno Pedro R.1,Bernardi Vi´ctor H.1,Lo´pez-Cue´llar Julio1,Newell John B.1,McMellon Charles1,Gold Herman K.1,Palacios Igor F.1,Fuster Valenti´n1,Fallon John T.1

Affiliation:

1. the Cardiac Unit, Massachusetts General Hospital, Harvard Medical School, Boston, and the Cardiovascular Institute (V.F., J.T.F.), Mount Sinai School of Medicine, New York, NY.

Abstract

Background Restenosis remains the major limitation of percutaneous coronary revascularization. Macrophages release cytokines, metalloproteinases, and growth factors that may induce smooth muscle cell migration and proliferation. We tested the hypothesis that primary lesions that develop restenosis after coronary atherectomy have more macrophages and smooth muscle cells than primary lesions that do not develop restenosis. Methods and Results Fifty patients with unstable angina were identified. Total and segmental areas were quantified on trichrome-stained sections of coronary atherectomy tissue. Macrophages and smooth muscle cells were identified by immunohistochemical staining. Restenosis, defined as >50% stenosis diameter by quantitative cineangiography, was present in 30 patients. The other 20 patients (<50% stenosis) constitute the “no restenosis” group. The percentages of smooth muscle cell areas were similar in specimens from patients with and without restenosis (57±5% and 52±6%) ( P =NS). However, macrophage-rich areas were larger in plaque tissue from patients with restenosis (20.4±2%) than in tissue from patients without restenosis (9.3±2%) ( P =.0007). Multiple stepwise logistic regression analysis identified macrophages as the only independent predictor for restenosis ( P =.006). Conclusions Macrophages are increased in coronary atherectomy tissue from primary lesions that develop restenosis, suggesting a possible role for macrophages in the restenotic process after percutaneous coronary intervention.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3